LIBTAYO 350 mg Konzentrat zur Herstellung einer Infusionslösung New

Recall | Medicines | 24/07/2026

The marketing authorisation holder informed its customers on July 23, 2026, that a crimping defect for the specified batch has been identified. For this reason, the mentioned batch is being recalled.

Name of the medicinal product LIBTAYO 350 mg Konzentrat zur Herstellung einer Infusionslösung
Marketing authorisation number(s) EU/1/19/1376/001
CIP code 4955351
Marketing authorisation holder Regeneron Ireland Designated Activity Company
Batch number(s) 8494100007
Expiry date 07/31/2027
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-5754
Email

Further inquiry note